A detailed history of Northern Trust Corp transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 496,370 shares of NAUT stock, worth $1.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
496,370
Previous 514,276 3.48%
Holding current value
$1.32 Million
Previous $1.51 Million 23.16%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$2.22 - $3.0 $39,751 - $53,718
-17,906 Reduced 3.48%
496,370 $1.16 Million
Q1 2024

May 14, 2024

SELL
$2.41 - $3.18 $47,093 - $62,140
-19,541 Reduced 3.66%
514,276 $1.51 Million
Q4 2023

Feb 13, 2024

SELL
$2.34 - $3.39 $1,172 - $1,698
-501 Reduced 0.09%
533,817 $1.6 Million
Q3 2023

Nov 13, 2023

SELL
$2.87 - $3.94 $2,723 - $3,739
-949 Reduced 0.18%
534,318 $1.69 Million
Q2 2023

Aug 11, 2023

BUY
$2.21 - $4.52 $199,346 - $407,713
90,202 Added 20.27%
535,267 $2.07 Million
Q1 2023

May 15, 2023

BUY
$1.67 - $2.77 $2,463 - $4,085
1,475 Added 0.33%
445,065 $1.23 Million
Q4 2022

Feb 13, 2023

SELL
$1.55 - $2.47 $2,765 - $4,406
-1,784 Reduced 0.4%
443,590 $798,000
Q3 2022

Nov 14, 2022

SELL
$1.96 - $3.13 $8,279 - $13,221
-4,224 Reduced 0.94%
445,374 $945,000
Q2 2022

Aug 12, 2022

BUY
$2.64 - $4.84 $816,483 - $1.5 Million
309,274 Added 220.4%
449,598 $1.21 Million
Q1 2022

May 13, 2022

SELL
$3.5 - $5.3 $14,080 - $21,321
-4,023 Reduced 2.79%
140,324 $609,000
Q4 2021

Feb 08, 2022

BUY
$4.45 - $6.21 $239,245 - $333,868
53,763 Added 59.35%
144,347 $748,000
Q3 2021

Nov 15, 2021

BUY
$6.14 - $10.1 $556,185 - $914,898
90,584 New
90,584 $556,000

Others Institutions Holding NAUT

About Nautilus Biotechnology, Inc.


  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $330M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.